InvestSMART

Pharmaxis Ltd (ASX: PXS) - Announcements

- Current share price for PXS : $0.027

ASX company news and announcements for Pharmaxis Ltd (PXS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pharmaxis Ltd (PXS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pharmaxis Ltd (PXS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pharmaxis Ltd (PXS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 4C - quarterly 29 Jan 2016 10:11AM $0.320 $0.027 fallen by 91.56%
- Appendix 3B - exercise of employee options 12 Jan 2016 5:33PM $0.355 $0.027 fallen by 92.39%
- Updated Investor Presentation 12 Jan 2016 8:35AM $0.335 $0.027 fallen by 91.94%
- Bronchitol Paediatric CF Trial Reports Postive Results 16 Dec 2015 8:29AM $0.250 $0.027 fallen by 89.20%
- Investor presentation 25 Nov 2015 4:38PM $0.225 $0.027 fallen by 88%
- Change of Director's Interest Notice 20 Nov 2015 8:47AM $0.230 $0.027 fallen by 88.26%
- Appendix 3B - grant of employee options 20 Nov 2015 8:45AM $0.230 $0.027 fallen by 88.26%
- Results of Meeting 20 Nov 2015 8:41AM $0.230 $0.027 fallen by 88.26%
- AGM Presentation 19 Nov 2015 2:19PM $0.228 $0.027 fallen by 88.13%
- Chairman's Address to Shareholders 19 Nov 2015 2:17PM $0.228 $0.027 fallen by 88.13%
- Appendix 4C - quarterly 23 Oct 2015 8:27AM $0.225 $0.027 fallen by 88%
- Quarterly Investor Update - September 2015 23 Oct 2015 8:27AM $0.225 $0.027 fallen by 88%
- Annual Report to shareholders 16 Oct 2015 1:08PM $0.240 $0.027 fallen by 88.75%
- Notice of Annual General Meeting/Proxy Form 16 Oct 2015 1:07PM $0.240 $0.027 fallen by 88.75%
- Investor presentation 6 Oct 2015 8:26AM $0.225 $0.027 fallen by 88%
- PXS Releases Successful Phase Results of Phase 1 Trial 22 Sep 2015 8:27AM $0.205 $0.027 fallen by 86.83%
- Pharmaxis Investor Briefing - Drug Discovery 22 Sep 2015 8:25AM $0.205 $0.027 fallen by 86.83%
- Change in substantial holding 10 Sep 2015 8:27AM $0.210 $0.027 fallen by 87.14%
- Appendix 3B - Exercise of employee options 11 Aug 2015 4:22PM $0.210 $0.027 fallen by 87.14%
- Investor presentation - August 2015 7 Aug 2015 8:47AM $0.210 $0.027 fallen by 87.14%
- Pharmaxis and Synairgen Announce Research Collaboration 5 Aug 2015 9:47AM $0.220 $0.027 fallen by 87.73%
- Change of Director's Interest Notice - McComas 4 Aug 2015 4:00PM $0.220 $0.027 fallen by 87.73%
- Appendix 3B - exercise of employee options 4 Aug 2015 3:51PM $0.220 $0.027 fallen by 87.73%
- Prposed Issue of Securities to Chief Executive Officer 31 Jul 2015 8:54AM $0.225 $0.027 fallen by 88%
- Change of Director's Interest Notice 31 Jul 2015 8:52AM $0.225 $0.027 fallen by 88%

551 - 575 of 836 results

Page 23 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.